Endocrinology

The British Medical Journal concluded that their research does "not provide evidence to support the use of aspirin in primary prevention of cardiovascular events and mortality."

Dr. Rasheed Balogun discusses the risk factors and rising worldwide incidence rates of chronic kidney disease.

Dr. Jay Cohen, an endocrinologist, discusses thyroid disease. He reviews the difference between hypo and hyper thyroidism, as well as the treatment of hypothryoidism. Memphis, Tenn. Call 901-763-3636 for more information.

Many of us will see a big increase in the number of patients who are simply unable to afford their medications.

Early warning signs of gestational diabetes can be found within nine weeks of gestation.

Lower levels of cortisol have been linked to antisocial behavior among male adolescents.

For those of you involved in the world of diabetes, a glucometer that measures glucose without pain is the next most desirable piece of technology.

Researchers developed a prediction tool to estimate the benefit of adding androgen deprivation therapy.

Healthcare professionals are recommended by the American College of Physicians to consider drug treatment for patients at risk for bone fractures due to osteoporosis or low bone density.

Endocrinology is not known for being very heavy on anything "tech", aside from insulin pumps and CGMS (continuous glucose monitoring sensor) devices.

Diabetes prevention strategies and the needed lifestyle and diabetes changes for improved health are well-known.

Louise B. Andrew is a fifth-generation physician who has made a career of serving health professionals in distress after her own experience dealing with a medical malpractice suit.

Electronic Health Record (EHR) systems hold great promise. However, like many new technologies, the difficulty of achieving EHRs' promise has been vastly underestimated, as have the risks. The current national initiatives pushing for widespread EHR implementation may be leading us into an unmapped minefield.

Consider this hypothetical situation: A patient with new onset of a major depression is evaluated by a physician who has found no evidence of suicidal ideation.

Many physicians are skeptical about getting involved in the practice, and rightfully so. Sermo and other online physician communities are rife with posts and comments from physicians who know colleagues who have stretched the truth or even lied on the stand because of personal beliefs or compensation.

One of the most important legal documents in your practice may have a significant impact on your finances. And even though you (or someone in your practice) agreed to abide by its terms and conditions, it's highly likely that you have never even read it.

According to an article published in the June 17, 2008 edition of the New York Times, declining reimbursements, managed care, physician shortages (especially in primary care), and concerns about malpractice are contributing to doctors' discontent.

David Van Avermaete, CEO of VeraLight, a medical device company, discusses the SCOUT DS non-invasive diabetes screening system and the importance of early detection in type 2 diabetes.

New findings published in the September issue of The Lancet show that a new formulation of the drug exenatide given once a week is more effective than when given twice a day, as is the current practice.

The Endocrine Society has released new clinical practice guidelines for the treatment of primary aldosteronism.

Manhattan Research, a healthcare market research company, released a survey on Monday announcing the top 10 pharmaceutical product sites visited by physicians.

A study published in the Canadian Medical Association Journal reveals that PPIs for treating acid reflux elevate the risk of osteoporosis-related fractures.

A recently launched study will examine the effects of obesity and explore methods for teaching participants about prevention.

A consensus statement published in the July issue of the Journal of Clinical Endocrinology and Metabolism indicates that the HbA1c test could be used to identify millions of people with undiagnosed diabetes.

Scientists from the University of Oxford have found that hormone replacement therapy in post-menopausal women increases the risk of gallbladder disease.

California has passed a law banning trans fats in restaurants, bakeries, delicatessens, cafeterias, and other businesses classified as “food facilities.”

Researchers around the globe are working on various breath-based technologies to not only diagnose illnesses, but identify the ingestion of drugs of abuse and provide defi nitive medication adherence documentation.

In June 2008, I participated in an online interview with Ed Silverman, author of the popular pharmaceutical industry blog Pharmalot.

Many of our patients are using the Internet to look up their diagnoses and medications as soon as they get home from our offices.

A year later, as we read and watch the breathless coverage devoted to recent moves by Google, Microsoft, and Apple, we are left asking "is healthcare IT worth the hype?"